News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
34,588 Results
Type
Article (1543)
Company Profile (4)
Press Release (33041)
Section
Business (15137)
Career Advice (90)
Deals (1933)
Drug Delivery (2)
Drug Development (4265)
FDA (1238)
Job Trends (1117)
News (22070)
Policy (1367)
Tag
Academia (32)
Allergies (14)
Alliances (1332)
ALS (15)
Alzheimer's disease (34)
Antibody-drug conjugate (ADC) (7)
Approvals (1257)
Artificial intelligence (2)
Autoimmune disease (1)
Bankruptcy (5)
Best Places to Work (1108)
Biosimilars (5)
Biotechnology (3)
Bladder cancer (14)
Breast cancer (25)
Cancer (155)
Cardiovascular disease (15)
Career advice (82)
CAR-T (2)
Cell therapy (9)
Cervical cancer (3)
Clinical research (3844)
Collaboration (20)
Compensation (6)
COVID-19 (53)
C-suite (4)
Cystic fibrosis (2)
Data (207)
Depression (3)
Diabetes (23)
Diagnostics (263)
Digital health (1)
Drug discovery (4)
Drug pricing (1)
Duchenne muscular dystrophy (6)
Earnings (13302)
Events (3049)
Executive appointments (12)
FDA (1416)
Frontotemporal dementia (1)
Funding (14)
Gene editing (2)
Gene therapy (9)
GLP-1 (27)
Government (89)
Guidances (59)
Healthcare (750)
Huntington's disease (1)
Immunology and inflammation (10)
Indications (3)
Infectious disease (58)
Inflammatory bowel disease (15)
Influenza (4)
Intellectual property (6)
Interviews (7)
IPO (1363)
IRA (1)
Job creations (114)
Job search strategy (78)
Kidney cancer (1)
Layoffs (6)
Legal (221)
Liver cancer (2)
Lung cancer (30)
Lymphoma (19)
Manufacturing (12)
MASH (7)
Medical device (684)
Medtech (684)
Mergers & acquisitions (587)
Metabolic disorders (48)
Multiple sclerosis (8)
NASH (1)
Neurodegenerative disease (4)
Neuropsychiatric disorders (1)
Neuroscience (79)
NextGen: Class of 2025 (150)
Non-profit (48)
Obesity (20)
Opinion (2)
Ovarian cancer (3)
Pain (5)
Pancreatic cancer (7)
Parkinson's disease (5)
Partnered (1)
Patents (9)
Patient recruitment (1)
Peanut (5)
People (1071)
Pharmaceutical (1)
Phase I (749)
Phase II (1197)
Phase III (1928)
Pipeline (288)
Policy (2)
Postmarket research (283)
Preclinical (307)
Press Release (1)
Prostate cancer (8)
Radiopharmaceuticals (12)
Rare diseases (24)
Real estate (153)
Regulatory (1201)
Reports (2)
Research institute (39)
Resumes & cover letters (7)
Rett syndrome (1)
RSV (2)
Schizophrenia (10)
Series A (2)
Sickle cell disease (3)
Special edition (1)
Spinal muscular atrophy (12)
Sponsored (1)
Startups (73)
Supply chain (3)
Tariffs (1)
Vaccines (22)
Weight loss (8)
Women's health (1)
Date
Today (16)
Last 7 days (125)
Last 30 days (254)
Last 365 days (2303)
2025 (885)
2024 (2448)
2023 (2752)
2022 (3478)
2021 (3044)
2020 (2478)
2019 (1794)
2018 (1500)
2017 (1260)
2016 (908)
2015 (1081)
2014 (673)
2013 (475)
2012 (563)
2011 (647)
2010 (526)
Location
Africa (20)
Alabama (4)
Arizona (14)
Asia (1948)
Australia (222)
California (397)
Canada (98)
China (24)
Colorado (19)
Connecticut (25)
Delaware (19)
Europe (4170)
Florida (61)
Georgia (15)
Idaho (1)
Illinois (46)
India (6)
Indiana (39)
Japan (17)
Kansas (3)
Louisiana (4)
Maine (5)
Maryland (53)
Massachusetts (290)
Michigan (17)
Minnesota (20)
Missouri (5)
Montana (3)
Nevada (6)
New Hampshire (7)
New Jersey (288)
New York (128)
North Carolina (83)
Northern California (183)
Ohio (14)
Oregon (2)
Pennsylvania (126)
Rhode Island (2)
South America (34)
Southern California (167)
Tennessee (7)
Texas (45)
United States (1785)
Utah (25)
Virginia (4)
Washington D.C. (9)
Washington State (36)
Wisconsin (1)
34,588 Results for "108".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Evaxion announces closing of $10.8 million public offering
February 2, 2025
·
4 min read
Press Releases
Recce Pharmaceuticals Announces A$5.0 million Placement & Launches A$10.8 million Entitlement Offer to Shareholders
April 11, 2025
·
8 min read
Press Releases
Cytonics Announces that Last Patient Completes Last Visit in First-in-Human Phase 1 Clinical Trial for CYT-108 as a Treatment for Osteoarthritis
April 1, 2025
·
6 min read
Biotech Bay
Day One Announces Sale of Priority Review Voucher for $108 Million
Day One Biopharmaceuticals, a commercial-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, announced it sold its Priority Review Voucher for $108 million to an undisclosed buyer.
May 30, 2024
·
3 min read
Press Releases
Cytonics Announces Successful Completion of Phase 1 Study for First Nine Patients in CYT-108 Clinical Trial
January 21, 2025
·
6 min read
Press Releases
Asphyxia Neonatorum Markets Expected to Grow at a CAGR of 10.8% during 2025-2035, Impelled by Advancements in Neuroprotective Therapies
January 24, 2025
·
9 min read
Press Releases
Immune-Onc Therapeutics Announces First Patient Dosed with IO-108 in a Randomized Global Phase 1b/2 Study of First-Line Treatment of Advanced Liver Cancer in Clinical Collaboration with Roche
February 27, 2025
·
6 min read
Press Releases
Aravax Completes Recruitment into Phase 2 Study of PVX108, a novel immunotherapy for the Treatment of Peanut Allergy
October 28, 2024
·
3 min read
Press Releases
Metastatic HER2-Positive Breast Cancer Market to Reach USD 3,108.1 Million by 2035, Impelled by Significant Progress in Monoclonal Antibodies, Antibody-Drug Conjugates (ADCs), and Tyrosine Kinase Inhibitors (TKIs)
February 6, 2025
·
12 min read
Press Releases
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma
November 7, 2024
·
7 min read
1 of 3,459
Next
